LACC1 功能丧失突变致遗传性幼年关节炎伴家族内表型异质性
研究一个近亲家系中常染色体隐性多关节型幼年特发性关节炎(JIA)伴肾淀粉样变和克罗恩病的表型与分子特征,发现 LACC1 纯合截短突变(p.Glu348Ter)致病,患者巨噬细胞无 LACC1 表达,且 C5 杂合变异可能减轻表型,LACC1 缺失巨噬细胞促炎细胞因子升高。
要点
- LACC1 纯合截短突变 p.Glu348Ter 可导致常染色体隐性多关节型 JIA 伴关节外表现。
- 同一家系中纯合突变携带者可无症状,提示 C5 杂合变异 p.Arg928Gln 可能修饰表型。
- LACC1 缺失巨噬细胞促炎细胞因子升高,提示野生型 LACC1 抑制促炎通路。
核心结论
- LACC1 功能丧失突变导致常染色体隐性 JIA,并扩展了其临床谱和家族内表型异质性。
- 补体 C5 变异可能调节 LACC1 相关疾病的表型严重程度。
- 野生型 LACC1 可能对促炎通路具有抑制作用。
研究设计与样本
- 对 15 名参与者进行全外显子测序或靶向 Sanger 验证。
- 在患者来源和 CRISPR/Cas9 生成的 LACC1 敲除巨噬细胞中分析 LACC1 表达和细胞因子。
主要发现
- 三名患病者和一名无症状家系成员携带 LACC1 纯合截短变异 p.Glu348Ter。
- 患者巨噬细胞中无内源性 p.Glu348Ter-LACC1 RNA 转录或蛋白表达,符合无义介导的 mRNA 降解。
- 无症状纯合子全外显子测序检出补体 C5 杂合变异 p.Arg928Gln,补体活性分析提示其可能为保护性表型修饰因子。
- LACC1 disrupted 巨噬细胞较野生型促炎细胞因子水平升高。
关键数值与推荐
- LACC1 纯合截短变异 p.Glu348Ter 在三人患病、一人无症状的家系中与疾病共分离。
- p.Glu348Ter 因导致 LACC1 蛋白序列提前终止、且不存在于种族匹配对照和公共变异数据库而被预测有害。
- 无症状纯合子携带 C5 杂合变异 p.Arg928Gln。
临床怎么用
- 对早发多关节型 JIA 伴关节外表现(如肾淀粉样变、克罗恩病)且有近亲婚配史者,可考虑 LACC1 基因检测。
- 发现 LACC1 致病突变时,可评估补体 C5 变异以辅助判断表型严重程度。
- LACC1 相关炎症可能由促炎细胞因子升高介导,但具体靶向治疗需进一步研究。
局限性
- 研究基于单一家系,样本量小,结论外推需谨慎。
- C5 变异 p.Arg928Gln 的保护作用基于家系内观察和补体活性分析,需更多功能研究验证。
- LACC1 抑制促炎通路的机制尚未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate phenotypic and molecular characteristics of a consanguineous family with autosomal-recessive, polyarticular, juvenile isiopathic arthriris (JIA) with extra-articular manifestations, including renal amyloidosis and Crohn's disease, associated with a novel homozygous truncating variant in LACC1. METHODS: Whole exome sequencing (WES) or targeted Sanger verification were performed in 15 participants. LACC1 expression and cytokine array were analysed in patient-derived and CRISPR/Cas9-generated LACC1-knockout macrophages (Mϕ). RESULTS: A homozygous truncating variant (p.Glu348Ter) in LACC1 was identified in three affected and one asymptomatic family member, and predicted harmful by causing premature stop of the LACC1 protein sequences, and by absence from ethnically-matched controls and public variation databases. Expression studies in patient-derived macrophages (Mϕ) showed no endogenous p.Glu348Ter-LACC1 RNA transcription or protein expression, compatible with nonsense-mediated mRNA decay. WES analysis in the asymptomatic homozygous subject for p. Glu348Ter-LACC1 detected an exclusive heterozygous variant (p.Arg928Gln) in complement component C5. Further complement activity analysis suggested a protective role for the p.Arg928Gln-C5 variant as a phenotypic modifier of LACC1-associated disease. Finally, cytokine profile analysis indicated increased levels of pro-inflammatory cytokines in LACC1-disrupted as compared with wild-type Mϕ. CONCLUSIONS: Our findings reinforce the role of LACC1 disruption in autosomal-recessive JIA, extend the clinical spectrum and intra-familial heterogeneity of the disease-associated phenotype, indicate a modulatory effect of complement factor C5 on phenotypic severity, and suggest an inhibitory role for wild-type LACC1 on pro-inflammatory pathways.
引用
- Butbul Aviel Y, Ofir A, Ben-Izhak O, et al. A novel loss-of-function mutation in LACC1 underlies hereditary juvenile arthritis with extended intra-familial phenotypic heterogeneity. Rheumatology (Oxford). 2021. PMID: 33493343. doi:10.1093/rheumatology/keab017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。